Bengtsson M, Broddefalk J, Dahmén J, Henriksson K, Kihlberg J, Lönn H, Srinivasa B R, Stenvall K
Astra Draco AB, Preclinical R&D, Lund, Sweden.
Glycoconj J. 1998 Mar;15(3):223-31. doi: 10.1023/a:1006988810800.
The 2-bromoethyl beta-glycosides of the disaccharide galabiose [Gal(alpha1-4)Gal] and the trisaccharides globotriose [Gal(alpha1-4)Gal(beta1-4)Glc] and 3'-sialyllactose [Neu5Ac(alpha2-3)Gal(beta1-4)Glc] have been prepared by improved routes. The 2-bromoethyl glycosides were then used in cesium carbonate promoted alkylations of the sulfhydryl groups of cysteine and homocysteine residues in T cell stimulating peptides. This convergent and general approach was used to prepare 16 neoglycopeptides which were obtained in 52-95% yields after purification by HPLC. 1H NMR spectroscopy revealed that beta-elimination and epimerization of neoglycopeptide stereocentres did not occur during the synthesis.
通过改进的路线制备了二糖半乳糖(Gal(α1-4)Gal)、三糖球三糖(Gal(α1-4)Gal(β1-4)Glc)和3'-唾液酸乳糖(Neu5Ac(α2-3)Gal(β1-4)Glc)的2-溴乙基β-糖苷。然后将2-溴乙基糖苷用于碳酸铯促进的T细胞刺激肽中半胱氨酸和高半胱氨酸残基巯基的烷基化反应。采用这种收敛性通用方法制备了16种新糖肽,经高效液相色谱纯化后,产率为52-95%。核磁共振氢谱显示,在合成过程中,新糖肽立体中心未发生β-消除和差向异构化。